Home›Companies›Biotech & Pharma›Human Longevity

Human Longevity, Inc.

Updated Oct 29, 2026·Latest SEC filing Aug 21, 2024·Suggest an edit

About Human Longevity

Human Longevity is a private company based in San Diego, California. It has reported $58,980,009 raised in three offerings on Form D since July 2019.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 13, 2023Apr 7, 2023amended Aug 21, 2024$31,999,999fully sold18$1.7MEquity, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Sep 27, 2021Oct 11, 2022$6,919,380of $11.7M target11$629KDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Jun 14, 2019Jul 1, 2019$20,060,630of $30.0M target1$20.0MEquityRule 506(b)Form D ↗
Total, three offerings$58,980,009

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Human Longevity's Form D filed Aug 21, 2024.

WH
Wei-Wu He
Director
JH
James Huang
Director
DK
David Karow
Executive officer and director
JH
James Hu
Secretary and director

Sources

  1. SECHuman Longevity, Inc. Form D, filed Apr 7, 2023
  2. SECHuman Longevity, Inc. filing history